| EyeSore vs King | 16–24 | 40.00% |
| EyeSore vs Steve | 17–18 | 48.57% |
| EyeSore vs Law | 20–13 | 60.61% |
| EyeSore vs Hwoarang | 15–14 | 51.72% |
| EyeSore vs Jin | 14–13 | 51.85% |
| EyeSore vs Kazuya | 13–10 | 56.52% |
| EyeSore vs Azucena | 11–6 | 64.71% |
| EyeSore vs Miary Zo | 10–7 | 58.82% |
| EyeSore vs Armor King | 3–13 | 18.75% |
| EyeSore vs Paul | 5–10 | 33.33% |
| EyeSore vs Bryan | 6–9 | 40.00% |
| EyeSore vs Lars | 4–10 | 28.57% |
| EyeSore vs Heihachi | 9–4 | 69.23% |
| EyeSore vs Dragunov | 5–7 | 41.67% |
| EyeSore vs Lili | 8–3 | 72.73% |
| EyeSore vs Jun | 8–3 | 72.73% |
| EyeSore vs Asuka | 3–7 | 30.00% |
| EyeSore vs Claudio | 4–5 | 44.44% |
| EyeSore vs Reina | 2–7 | 22.22% |
| EyeSore vs Yoshimitsu | 4–4 | 50.00% |
| EyeSore vs Jack-8 | 4–4 | 50.00% |
| EyeSore vs Eddy | 3–4 | 42.86% |
| EyeSore vs Nina | 1–5 | 16.67% |
| EyeSore vs Leroy | 3–3 | 50.00% |
| EyeSore vs Clive | 3–3 | 50.00% |
| EyeSore vs Xiaoyu | 2–3 | 40.00% |
| EyeSore vs Alisa | 0–5 | 0.00% |
| EyeSore vs Devil Jin | 1–3 | 25.00% |
| EyeSore vs Lidia | 2–2 | 50.00% |
| EyeSore vs Raven | 1–2 | 33.33% |
| EyeSore vs Fahkumram | 2–1 | 66.67% |
| EyeSore vs Lee | 2–0 | 100.00% |
| EyeSore vs Zafina | 2–0 | 100.00% |
| EyeSore vs Victor | 1–0 | 100.00% |
| EyeSore vs Anna | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.